The Cost-Effectiveness of Frontline Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia: In Pursuit of Treatment-Free Remission and Dose Reduction. - Metsemakers, Sanne J.J.P.M.; Hermens, Rosella P.M.G.; Ector, Geneviève I.C.G.; Blijlevens, Nicole M.A.; Govers, Tim M. (Value in Health, 2025)